Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
EV/Core EBITDA

    Back to All Ratios
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 22.2310.6420.2616.0229.75

What is the latest EV/Core EBITDA ratio of KILITCH DRUGS (INDIA) ?

The latest EV/Core EBITDA ratio of KILITCH DRUGS (INDIA) is 22.23 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202422.23
Mar202310.64
Mar202220.26
Mar202116.02
Mar202029.75

How is EV/Core EBITDA of KILITCH DRUGS (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2024 22.23
108.93
Mar2023 10.64
-47.48
Mar2022 20.26
26.47
Mar2021 16.02
-46.15
Mar2020 29.75 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare EV/Core EBITDA ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹771.8 Cr 0.2% -9.6% 36.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,383.0 Cr 2.6% -5.1% -6.4% Stock Analytics
DIVIS LABORATORIES ₹162,026.0 Cr -0.5% -10.1% 21.8% Stock Analytics
CIPLA ₹126,159.0 Cr 4.7% 4.8% -4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,450.0 Cr 0.6% 5.2% 8.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,536.0 Cr 4.3% -0.7% -11.4% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

0.2%

-9.6%

36.7%

SENSEX

-0%

-2.1%

1.1%


You may also like the below Video Courses